Pioneering Artificial Pancreas, Developed at UVA, to Undergo Final Tests

UVA Today
January 6, 2016

A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning early this year.

Agenus Acquires PhosImmune with a Novel Class of Cancer Neoantigens

Business Wire
December 24, 2015

LEXINGTON, Mass. -- Agenus Inc. (NASDAQ: AGEN), an immunotherapy company developing innovative treatments for cancer, today announced that it has acquired privately-held PhosImmune Inc., a company that has discovered an entirely new portfolio of cancer neoantigens. The acquisition provides Agenus the ability to accelerate the development of new cancer vaccines and other single agent immuno-oncology approaches, as well as combination therapies.

Inventive UVA Professor Boosts Communications Around the Globe

UVA Today
December 22, 2015

When one thinks of influential Campbells, the mind usually turns to a certain soup-making family. Many people outside the world of engineering may not know the University of Virginia’s Joe C. Campbell, but chances are that they use his inventions much more often than they heat up a bowl of chicken noodle.

New Seed Fund to Speed UVA Innovation and Research to Market

UVa Today
November 17, 2015

Starting in 2016, the University of Virginia will be propelling entrepreneurship into the market like never before. The University’s new Seed Fund will deploy $10 million over 10 years to help commercialize UVA technologies and opportunities.

PsiKick Raises $16.5M Series B Round to Power a Batteryless Revolution in the ‘Internet of Things’

Business Wire
December 18, 2015

PsiKick, the self-powering Internet of Things (IoT) systems company, has announced a $16.5M Series B financing, led by Osage University Partners and joined by existing investors New Enterprise Associates (NEA), the University of Michigan Investment in New Technologies Fund (MINTS) as well as individual angels. This brings total funding raised by the Company to over $22M. 

Governor McAuliffe Announces New Funding for MACH37 Cyber Accelerator

December 8, 2015

Governor Terry McAuliffe has announced a significant new public-private partnership that will speed the launch of new cybersecurity products and companies in Virginia, leading to new jobs and revenue. General Dynamics Mission Systems will now serve as a sponsor of the MACH37 Cyber Accelerator through an innovative funding and mentorship agreement.

Tears of Joy: UVA Start-up Seeks to Bring New Eye Therapy to Millions

UVA Today
December 3, 2015

Despite spending billions of dollars annually on prescription and over-the-counter eye care products, millions of Americans suffer from chronic dry eye with few or no options for lasting relief. TearSolutions, a new University of Virginia-based start-up, is trying to change that.

Cavion LLC Closes $5M Round of Convertible Debt

Business Wire
November 10, 2015

Cavion LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of neurologic diseases and solid tumor cancers, announced today that it has closed a $5 million private placement of convertible notes with new and existing investors.

TearSolutions Raises $3M Series A Round to Advance the Treatment of Dry Eye

November 9, 2015

RIVANNA Commences Sales of Accuro™ to Address Spinal Anesthesia

Business Wire
November 5, 2015

Rivanna Medical, a Charlottesville-based biotechnology company, has announced that it has begun selling its Accuro device to anesthesia providers as a result of a successful product launch at the annual meeting of the American Society of Anesthesiologists (ASA) in San Diego. The company also announced that it is continuing discussions with three potential corporate partners.